Neurotransmitters

Mood disorders and mental health illnesses affect 46.6 million adults in the US alone. Neurotransmitters influence and regulate a wide range of processes, including mental performance, emotions, pain response, and energy levels. Hormones, especially adrenal and sex hormones, are interconnected with neurotransmitters. An imbalance in adrenal and sex hormones could lead to neurotransmitter imbalances, which could revert to hormonal imbalances, resulting in a vicious cycle.

The Neural Zoomer Plus test is also  crucial because autoimmune disorders collectively affect 5-8% of the US population, with the prevalence on the rise. Autoimmune diseases have the potential to target any structure within the central or peripheral nervous system in a highly specific manner. The Neural Zoomer Plus is a vital tool as it can detect underlying inflammatory responses, getting to the root cause of symptoms and uncovering potential autoimmune diseases that may be responsible. By pinpointing the mechanisms behind neural autoimmunity, this test enables healthcare providers to develop personalized treatment plans aimed at improving health outcomes in this complex realm of disease.

The Neural Zoomer Plus test measures several markers related to various aspects of neurological health. These markers include antibodies related to demyelination antigens, myelin proteins, neurofascin, MAG, and autoantibodies associated with optic and autonomic nervous system disorders. Additionally, the test covers markers for brain inflammation, brain autoimmunity, peripheral neuropathy, infections, blood-brain barrier disruption, and neuromuscular disorders. Some specific markers measured in the test include antibodies against neurotransmitter receptors, various brain proteins, viruses like HSV and CMV, and autoimmune markers related to specific regions like the cerebellum and Purkinje cells.

The symptoms that suggest the Neural Zoomer Plus test may be appropriate include hyperactivity or nervous energy, depression, irritability, lack of concentration/brain fog, migraines or headaches, muscle spasms, anxiety/fears/uneasiness, forgetfulness, body aches, tremors.

The Neural Zoomer Plus test is designed for individuals experiencing a range of symptoms, including hyperactivity or nervous energy, depression, irritability, lack of concentration/brain fog, migraines or headaches, muscle spasms, anxiety/fears/uneasiness, forgetfulness, body aches, and tremors. If you find yourself dealing with any of these symptoms, the Neural Zoomer Plus test may be beneficial for you.

When considering the potential root causes of neurological inflammation that can be unveiled through the Neural Zoomer Plus test, it is essential to recognize the intricate nature of autoimmune diseases. The Neural Zoomer Plus pinpoints the mechanisms behind neural autoimmunity, shedding light on the underlying inflammatory responses that contribute to symptoms. By revealing autoimmune diseases as potential culprits, this test enables the development of targeted treatment plans to enhance health outcomes in the realm of complex diseases. Moreover, treatments focused on fortifying the hyper-permeable intestinal barrier offer promising avenues for reversing or alleviating autoimmune disease symptoms. For a more comprehensive assessment of potential root causes of neurological inflammation, complementary tests such as the Wheat Zoomer, Lectin Zoomer, and Connective Tissue Disease Panel (ENA-11) can be conducted in conjunction with the Vibrant Neural Zoomer Plus. This multifaceted approach ensures a thorough exploration of the factors contributing to neurological inflammation, guiding towards more effective management strategies.

The Neural Zoomer Plus test measures immune reactivity in the brain and peripheral nervous system by assessing an individual's reactivity to 48 neurological antigens, which may be connected to various neurologically related diseases. In addition to evaluating levels of important hormones and chemicals in the brain and peripheral nervous system, the test utilizes these markers to detect underlying inflammatory responses that could be causing symptoms associated with mood, memory, aging, balance, nervous function, movement, pain, and more. Individuals who have been diagnosed with or suspect neurological inflammation or autoimmune disease may find benefit from this comprehensive panel.

The purpose of the Neural Zoomer Plus test is to "measure immune reactivity to structures, tissues, cells, and chemicals in the brain and peripheral nervous system." This comprehensive test utilizes 48 markers to detect underlying inflammatory responses that may be causing symptoms associated with various neurological functions such as mood, memory, aging, balance, nervous function, movement, pain, and more. By identifying autoimmune diseases and neurological inflammation, the Neural Zoomer Plus test provides valuable insights into the root causes of symptoms, enabling healthcare providers to create personalized treatment plans that aim to improve overall health outcomes.

SYMPTOMS AND RISK FACTORS

• Hyperactivity or nervous energy
• Depression
• Irritability
• Lack of concentration/brain fog
• Migraines or headaches
• Muscle spasms
• Anxiety, fears, or uneasiness
• Forgetfulness
• Body aches
• Tremors
• Balance problems
• Memory loss
• Trouble focusing
• Vision or hearing loss
• Mood changes or disorders
• Chronic or acute fatigue
• Joint pain
• Gastrointestinal symptoms

In addition to the above symptoms, individuals experiencing neurological inflammation or autoimmune diseases may also encounter a range of other manifestations. These can include hyperactivity or nervous energy, indicating potential disruptions in the nervous system. Furthermore, symptoms like anxiety, fears, or uneasiness, as well as vision or hearing loss, may present themselves, pointing to the multifaceted nature of these conditions. It is important to recognize the diverse array of symptoms associated with these health challenges to ensure a comprehensive understanding and appropriate management of the underlying issues.